Jupiter Topco LLC Makes New Investment in Docusign Inc. $DOCU

Jupiter Topco LLC bought a new position in shares of Docusign Inc. (NASDAQ:DOCU) during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 92,200 shares of the company’s stock, valued at approximately $4,096,000.

Several other institutional investors and hedge funds have also recently modified their holdings of the business. Hsbc Holdings PLC acquired a new position in Docusign in the 2nd quarter worth about $5,156,000. Primecap Management Co. CA purchased a new stake in shares of Docusign in the second quarter valued at approximately $3,776,000. Canada Pension Plan Investment Board acquired a new position in shares of Docusign during the 2nd quarter worth approximately $13,517,000. Legal & General Group Plc acquired a new position in shares of Docusign during the 2nd quarter worth approximately $22,002,000. Finally, The Manufacturers Life Insurance Company purchased a new position in shares of Docusign during the 2nd quarter valued at approximately $6,006,000. Hedge funds and other institutional investors own 77.64% of the company’s stock.

Insider Buying and Selling at Docusign

In other news, insider James P. Shaughnessy sold 12,000 shares of the stock in a transaction dated Wednesday, July 1st. The shares were sold at an average price of $45.54, for a total value of $546,480.00. Following the completion of the sale, the insider directly owned 52,815 shares in the company, valued at $2,405,195.10. This represents a 18.51% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director James A. Beer sold 450 shares of the business’s stock in a transaction dated Friday, August 28th. The stock was sold at an average price of $64.02, for a total transaction of $28,809.00. Following the transaction, the director owned 14,586 shares in the company, valued at $933,795.72. The trade was a 2.99% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 90,965 shares of company stock valued at $4,341,688. 0.59% of the stock is owned by company insiders.

Docusign Price Performance

Shares of NASDAQ:DOCU opened at $64.64 on Wednesday. The business’s 50 day moving average price is $54.35 and its 200-day moving average price is $49.43. The firm has a market capitalization of $12.34 billion, a PE ratio of 41.97, a P/E/G ratio of 1.92 and a beta of 0.90. Docusign Inc. has a 1 year low of $40.16 and a 1 year high of $86.65.

Docusign (NASDAQ:DOCU) last issued its quarterly earnings results on Thursday, June 4th. The company reported $1.09 EPS for the quarter, topping the consensus estimate of $0.99 by $0.10. The firm had revenue of $830.24 million during the quarter, compared to analysts’ expectations of $824.71 million. Docusign had a return on equity of 17.48% and a net margin of 9.59%.The firm’s revenue for the quarter was up 8.7% on a year-over-year basis. During the same period in the previous year, the business earned $0.90 earnings per share. As a group, analysts expect that Docusign Inc. will post 2.06 earnings per share for the current year.

Analyst Ratings Changes

A number of equities research analysts recently issued reports on the stock. BTIG Research dropped their price target on shares of Docusign from $70.00 to $60.00 and set a “buy” rating on the stock in a research note on Friday, June 5th. Weiss Ratings upgraded shares of Docusign from a “hold (c-)” rating to a “hold (c)” rating in a research report on Tuesday, August 25th. Wells Fargo & Company decreased their price objective on shares of Docusign from $60.00 to $55.00 and set an “equal weight” rating on the stock in a report on Friday, June 5th. Wall Street Zen lowered shares of Docusign from a “strong-buy” rating to a “buy” rating in a research report on Sunday, August 2nd. Finally, UBS Group set a $60.00 target price on shares of Docusign in a research note on Friday, June 5th. Four analysts have rated the stock with a Buy rating, fourteen have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Docusign currently has a consensus rating of “Hold” and an average price target of $60.27.

About Docusign

DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.